JENNIFER AMOS: Open Payments
NPI 1043761000 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,307 in 53 payments from 8 companies in 2025. Trend: 2023 $1,458 · 2024 $995 · 2025 $1,307
Food & beverage: $1,203Education: $104
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $479 |
| Teva Pharmaceuticals USA, Inc. | 10 | $250 |
| E.R. Squibb & Sons, L.L.C. | 10 | $240 |
| Otsuka America Pharmaceutical, Inc. | 8 | $161 |
| Vanda Pharmaceuticals Inc. | 6 | $102 |
| Janssen Pharmaceuticals, Inc | 1 | $40 |
| PFIZER INC. | 1 | $20 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: INGREZZA, COBENFY, UZEDY, FANAPT, REXULTI, ABILIFY MAINTENA, INVEGA SUSTENNA, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
